Aims The purpose of this study was to assess risk factors for sudden death after discharge from hospital for myocardial infarction in an era in which 50% of patients receive thrombolytic drugs.
Introduction
In spite of modern therapies for acute myocardial infarction, it is generally accepted that the surviving patients remain at an elevated risk for subsequent sudden and cardiac death [1, 2] . In studies targeting a large infarction population, class I antiarrhythmic drugs fail to reduce total mortality [3] . From the investigated class III drugs, only amiodarone is moderately protective against cardiac arrhythmic death [4] [5] [6] [7] . These trials focused on survivors with a low ejection fraction [5] , or with spontaneous (asymptomatic) ventricular arrhythmias [7] . The consequence of these failures is that investigations focus on high risk groups. The idea is to reduce cardiac and arrhythmic mortality by isolating and treating high-risk patients [8] . Implantable cardioverter-defibrillators are becoming attractive as a prophylactic alternative for selected patients, as they are life-saving for survivors of acute myocardial infarction who have a reduced ejection fraction, ventricular tachycardia on the Holter, and persistent inducible ventricular arrhythmias [9, 10] . Risk stratification programmes are therefore more important than ever. It has been suggested that several non-invasive risk indicators have a high predictive accuracy for cardiac arrhythmic or sudden death [11, 12] . However, modern, prospective data from the thrombolytic era are rare [1, 13] . We prospectively collected data on risk variables in a study with the acronym MIRRACLE (Myocardial Infarction Risk Recognition And Conversion of Life threatening Events into survival). The first aim of this project was to study factors which contribute to mortality after hospital discharge following acute myocardial infarction. Second, it would allow analysis of the treatment of the infarction in Belgium in a consecutive series of patients, admitted in the thrombolytic era [14] . The third goal was to identify, prospectively, patients with an established high-risk profile as potential candidates for the implantable defibrillator [15] . This report describes the group who were discharged alive, and relates functional and electrical risk factors to subsequent mortality over the first 24 months (total mortality, cardiac mortality, and sudden death).
Material and Methods

General study organization
Prospective registration of all consecutive patients with acute myocardial infarction was performed in 11 community and private hospitals in Flanders between 24 January 1993 and 20 August 1995 [14] . The list of involved (non-academic) centres is given in Appendix 1. All hospitals had at least two cardiologists in the team. Only one hospital had interventional cardiological and surgical facilities for percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG). One hospital acquired diagnostic coronary angiography facilities during the study period. In all the others the cardiologists performed angiography at other institutions, and therefore had easy access to diagnostic and interventional facilities.
As the main goal was to study long-term survival and sudden death, centres were only allowed to participate if no conflicting studies were being performed which incorporated prescription of antiarrhythmic drugs (in particular EMIAT and SWORD, which were conducted at the same time) [4, 5] . Recruitment started after initiating visits by a study nurse and one of the major investigators, in order to be sure that all study forms were uniformly completed, and to verify that the equipment for Holter recording and signal averaging was comparable in all centres. The study was coordinated at the University of Ghent, Belgium, with a grant from the National Fund for Scientific Research. Subsequent support was provided by Medtronic Europe. Ethics committee approval was granted to study a subgroup of patients with a high-risk profile with programmed electrical stimulation with or without an implantable cardioverter defibrillator.
Risk stratification programme
All patients admitted with acute myocardial infarction (transmural and subendocardial) had to be in the registry, and were to be risk-stratified within 21 days. Admission data included the admission ECG and whenever possible NYHA and Killip functional class. Complete information with respect to therapy on admission was prospectively recorded on the data sheets. All requested additional studies had to be done within days 7 to 12. Registration forms, admission and discharge ECGs, signal averaged ECGs, and Holter tapes were sent, with the result of the left ventricular ejection fraction, to the coordinating centre (Fig. 1) . The coordinating centre reviewed the admission data, classified the infarction according to definitions as below, and performed risk stratification after central review of the data, according to pre-set criteria. The prospectively defined criteria were a reduced left ventricular ejection fraction (c35%), combined with: (1) decreased heart rate variability, defined as standard deviation of normal RR intervals on Holter c50 ms; or (2) abnormal signal averaged ECG, with late potentials defined as filtered QRS duration d110 ms and low amplitude signal duration d40 ms, in the absence of bundle branch block or (3) new or transient bundle branch block; always after transmural acute myocardial infarction [1, 11, 16] . The patient would, according to these criteria, be labelled as high or low risk and followed by the referring centre.
Other conventional and investigational risk variables on the discharge electrocardiogram, such as heart rate, the QT interval and QT dispersion, and spontaneous ventricular arrhythmias on the Holter tape would be collected in parallel, but would not influence the prospective labelling [17] . Assessment and treatment of residual ischaemia was left to the discretion of the referring centre. Discharge therapy, including intervention with PTCA and CABG was recorded, and included in the final data analysis. Risk variables were defined as admission and discharge variables, according to the time when they were sampled. The strongest admission and discharge variables were to be combined. and/or ventricular tachycardia. Heart rate variability was studied using edited, digitized data in the time domain. Only tapes with a recording time of more than 16 h were included. Only the standard deviation of normal RR intervals over the entire recording was prospectively used. The average RR and QT intervals over 24 h were also stored (analysed with ELATEC software).
Definitions of acute myocardial infarction and the admission electrocardiogram
Signal averaging electrocardiography
For signal averaged ECGs, a noise level below 1·0 V was required. The filter setting was between 40 and 250 Hz. Unfiltered QRS duration, filtered QRS duration, low amplitude signal duration, and the root mean voltage of the last 40 ms were recorded. A filtered QRS duration of d110 ms with a low amplitude signal duration of d40 ms were considered to indicate the presence of late potentials.
Discharge electrocardiogram
RR-and QT-intervals were measured automatically in all 12 leads of the standard electrocardiogram, after digitizing the electrocardiogram obtained at discharge (preferably taken at 50 mm . s 1 ). We analysed the QT in all leads, to study the potential value of inter-lead differences. The maximal QT (QT max) was determined. The QT interval in V 4 and QT max was corrected with Bazett's formula. QT dispersion was calculated, and correction was performed, taking the next-to-the longest and the next-to-the shortest interval (QT dispersion ) [18] . For RR intervals, an average of four consecutive intervals was measured.
Ejection fraction
Determination of the left ventricular ejection fraction was performed in all cooperating centres with technetium 99 scanning, between days 7 and 12.
Follow-up
A final visit was made 1 year after inclusion to ensure proper documentation for each patient; follow-up at 2 years was completed. Vital statistics were supplied by the cardiologist, general practitioner, and the official death registry until September 1997. Sudden cardiac death was defined as death without prodromi, occurring within 1 h after the first symptom, or unwitnessed death, which was unlikely to have other aetiologies. Cardiac death and non-cardiac death were also classified. All available information from hospital records and the next of kin was used for this classification.
Statistical analysis
Univariate analysis was performed with chi-square analysis. When groups became too small, Fisher's exact test was applied. To dichotomize variables, various cut-off values were selected, after calculating differences and 95% confidence intervals, to maximize predictive values. The dichotomized variable set is presented in Appendix 2. Only variables that were significant or borderline significant in univariate analysis were kept for further multivariate analysis. Multivariate analysis (logistic regression, with the three vital statuses as dependent variables) and survival studies (Kaplan-Meier analysis) were done with the SPSS package (version 7.5).
For the multivariate analysis, 95% confidence intervals were calculated. When a patient had a recurrence, his survival of the first infarction was censored at the time of the recurrence. A P level <0·05 was considered as significant. A P level between 0·05 and 0·1 was considered of borderline significance.
Results
Total group and in-hospital mortality
The total registry included 799 cases (787 patients). The mean age of the 787 patients was 67 12 years (range 30 to 97 years). 539 patients were male (68%), 248 were female (32%). In total, 126 patients (16%) had clinical evidence of a recurrent infarction. The site was (transmural) anterior in 222 cases (28%), (transmural) inferior in 281 (35%), and other transmural sites in 36 cases (5%). A non-Q wave infarction was noted in 210 cases (26%). It was impossible to localize the site in 50 cases (6%). Bundle branch block was present in 68 cases (9%). It was new (and permanent) in 14 of these cases (left sided in three). It was new (and transient) in another seven cases (left sided in three). Fifty percent of the patients (397 cases) were given thrombolytics. Beta-blockers were given within 24 h after admission (oral or intravenously) in 365 patients (46%). Acetylsalicylic acid was given to 644 patients (81%) in the acute phase. A total of 89 patients died (11%). The acute (in-hospital) phase was survived by 710 patients. Details describing risk variables for in-hospital death have been published elsewhere. The in-hospital mortality of a first infarction was 8·3%, that of recurrent infarction 12·6% (difference not significant). Transmural infarction had a mortality of 8·3%, subendocardial infarction of 11·4% (difference not significant).
Description of the cohort at hospital discharge
The mean age of the 710 patients was 66 12 years (range 30 to 95 years). A total of 508 patients were male (71·5%), 202 were female (28·5%). In total, 585 patients (84%) had a first infarction, 110 had a recurrence (16% 
Mortality: overall results
Two patients were lost for follow-up. Total mortality over the first 24 months was 11·7% (83/708); the survival rate is shown in Fig. 2 . The cause of death was available in 74 patients (89% of those who died). Non-cardiac death occurred in 16 patients (21·6% of those for whom the mechanism was known). Cardiac mortality was observed in 58 patients (78·4% of those for whom the mechanism was known); sudden death occurred in only 12 patients (16·2%).
Only patients with a transmural acute myocardial infarction were to be prospectively studied. Results for transmural infarction are shown in Table 1 . This reduces the number at high risk according to the protocol to 25.
From the 25 patients who met the pre-defined high-risk criteria (low left ventricular ejection fraction, transmural acute myocardial infarction), only three died during the first 2 years. The death mechanism was cardiac (nonsudden) in two, and cancer in the last patient. The patient with cancer was one patient out of 10 with a low standard deviation of the normal RR interval, and 2/12 with late potentials (after exclusion of bundle branch block).
Cardiac mortality: overall results
Cardiac death was observed in 58 (8%) cases. Recurrent infarction was noted five times; pulmonary oedema six, cardiogenic shock five, chronic failure 15, other vascular reasons four times; sudden arrhythmic death was included in this category and was observed in 12 cases. Several patients had a witnessed in-hospital death after readmission. Table 2 shows the continuous risk variables, Table 3 the dichotomized variables for the discharged patients with respect to cardiac death.
Univariate predictors of cardiac mortality
Multivariate predictors of cardiac mortality
For cardiac mortality, only NYHA class was a predictive admission variable (P<0·02). For functional and electrical variables, late potentials (P<0·002) and RR intervals shorter than 800 ms on the discharge ECG (P<0·0005) were important (Figs 3 and 4) . When discharge therapy was included in the analysis, only short RR intervals remained statistically significant (P<0·05).
Sudden cardiac mortality: overall results
Only 12 cases of sudden death were reported (1%). This was instantaneous in at least four cases. It is possible 
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that some patients with cardiac death had (non-sudden) arrhythmic death, but this was not specifically recorded. Table 4 shows the continuous risk variables, Table 5 the dichotomized variables for the discharged patients with respect to sudden death. Whereas most variables that were important for cardiac death remain of value in sudden death, some parameters became of borderline value. The value of discharge therapy was diminished with respect to its value in cardiac and total death.
Univariate predictors of sudden death
Multivariate predictors of sudden death
From the admission parameters, NYHA class was important (P<0·05). For functional and electrical parameters, only the filtered QRS duration remained important.
Combining parameters to predict survival
and sudden death Table 6 shows the combination of the strongest admission pre-discharge variables for the prediction of total cardiac and sudden mortality. The log rank shows differences between the four strata. The positive predictive values reflect mortality. Four clinical admission variables, (including the ejection fraction) combined with one of four discharge variables yielded positive predictive values above 30% for total mortality. Cardiac mortality was comparable to total mortality, except for beta-blockers, which were not significant. NYHA functional class was not used as a basis for stratification, except with QRS duration. For sudden death, the positive predictive values were lower. NYHA class (the strongest clinical variable) was only useful in combination with filtered QRS duration. Anterior site was used much more in combination with electrical variables, but yielded low positive predictive values. A combination of the two strongest (pre-)discharge electrical variables yielded a positive predictive value of 27% (Fig. 5 ).
Discussion
The total mortality after hospital discharge in our unselected, study population consisting of consecutive patients with all types of infarctions, remains relatively high (12%), in spite of the fact that thrombolytic therapy was used in 50% of our patients, and ACE inhibitors were given to those with a poor left ventricular function. In contrast, the sudden death rate is low. This low number (1·7%) implies that statistics become difficult, and that real prediction of sudden death for the individual is almost hypothetical. This low number is in agreement with recent investigations, which used the same definition of sudden death [19] . Furthermore, the fact that antiarrhythmic drugs were avoided in the trial can 
Mortality after infarction 1219
also explain the low number of sudden deaths (one patient received amiodarone for sustained ventricular tachycardia [3, 20] ).
Conventional risk indicators for sudden death and risk stratification policies
Some known high-risk indicators for sudden death were again recognized as such in our study with univariate analysis (high age, indicators of poor left ventricular function and electrocardiographic indices such as bundle branch block, asymptomatic arrhythmias on the Holter, a long corrected QT and abnormalities on the filtered electrocardiogram). A reduced standard deviation and increased QT dispersion seemed not to be related to sudden death, as were some interventions on admission and at discharge (e.g. thrombolysis). Conventionally, prophylactic interventions are designed for patients of younger age, with poor left ventricular function (usually determined with ejection fraction measurements) and/or with the presence of electrical risk variables [5] . We will analyse our findings with respect to this approach.
Age
The Multicenter Postinfarction Research Group reported that, in a population of a similar size, and a follow-up of 22 months, 12% had died [21] . However, this number was obtained in a study group with an age limit of 70 years; in our register for this age group we have a mortality of 6·7%, with only three cases of sudden death below 70 years. This explains why in our study high age was identified as one of the most important univariate variables for sudden death. Our low number for sudden death contrasts with data showing 5% arrhythmic death, including sudden death, from a population younger than 75 years [2] . It was 4% in another population younger than 70 years [13] . More recent attempts to identify high risk patients limited the stratification programme to patients with an age below 75 years, and they also showed a low sudden death rate (3·6% over 3 years) [19] . We feel that it is not logical to limit risk stratification to the younger age group, as patients above 70 carry the highest risk.
Left ventricular function
The number of patients (7/12) dying with a 'good' ejection fraction (>35%) makes this often used clinical variable a less useful basis for further stratification of the risk for sudden death. It is clear that the lower the left ventricular ejection fraction, the higher the total mortality [21, 22] . By using the clinical functional admission status we defined an optimal admission parameter; it seems logical to exclude those with NYHA class I from further risk stratification [23] . The power of using the NYHA classification as a basic variable to predict sudden death was enhanced by combining it with the filtered QRS duration. However, the number of falsepositive predictions is relatively high.
Thrombolytic therapy
The effect of thrombolytic therapy (multivariate analysis) seems to be most clear in relation to in-hospital mortality [15] . Its effect in larger trials was most clear for total and cardiac death after discharge. It was not important in our study in univariate analysis for sudden death. Thrombolysis did not reduce the incidence of spontaneous ventricular arrhythmias, and often comes too late to protect ventricular function. However, it is known that the inducibility of ventricular tachycardia [24] and the prevalence of late potentials diminish after successful thrombolytic therapy [25] [26] [27] . This could be an indicator that the substrate for sudden death is less frequently present after such therapy.
Anterior infarction
The fact that the anterior site was related to sudden death and not to cardiac death in general made it an interesting starting point for further risk assessment [28] . However, in multivariate analysis, infarction site was not important. In combination with electrical parameters, no improvement was seen compared to functional class, and the number of false-positive predictions remains high.
Recurrent infarction
It is logical that patients after a recurrence face more problems. The disease is more advanced, and patients are often older, and the probability of cardiac death is higher. A history of multiple infarctions was associated with an increased risk for recurrent ventricular tachycardia [29] . However, when we were analysing the sudden death risk, recurrence was not helpful as an independent parameter.
Electrical parameters
It is also noticeable that the presence of bundle branch block was not important in multivariate analysis on the long-term outcome, in contrast to short-term evolution [16] . However, the fact that a filtered QRS duration is the most important variable (also when bundle branch block is excluded) supports evidence that intraventricular conduction delay (here detected with averaging techniques) is an important issue. The combined end-point of filtered QRS duration and low amplitude signals was not significant. This finding has been reported by other investigators, who showed that sudden death is determined by QRS duration, while conventional late potentials only deal with ventricular tachycardia [28] . A reduced heart rate variability is another indicator of risk for subsequent mortality [11] . In our study, a low standard deviation was never related to mortality; it correlated primarily with left ventricular ejection fraction [30] . The same finding is true for a shorter RR interval: fast heart rates reflect a poor cardiac function, and this probably explains why this parameter is so important in the prediction of cardiac death [31] . However, when we focused on sudden death in the multivariate analysis, and in combination, it was also not important.
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The same occurred with the corrected QT interval: the corrected QT interval therefore seems to have no independent value in the recognition of patients at risk for sudden death after myocardial infarction. It should be pointed out that the initial, often quoted data, relate to sudden death, but without a clear definition of this event [17] . Our results parallel the findings in a large population [32] . In patients without cardiac dysfunction and a corrected QT >440 ms, a 2·3 times higher risk for sudden death was detected compared with a corrected QT of 440 m or less. In contrast, for patients with evidence of cardiac dysfunction (more comparable to our study population) the relative risk of corrected QT prolongation was not increased.
Although differences in QT dispersion between patients with and without malignant ventricular arrhythmias and underlying ischaemic heart disease are reported in the literature, we could not demonstrate any difference in QT dispersion between patients with sudden cardiac death and others in this registry [33] . We were not able to demonstrate a relationship between myocardial infarct size and QT dispersion for patients with underlying ischaemic heart disease and malignant ventricular tachycardia [34] . The importance of electrical variables was emphasized when the combination of late potentials (rather: a long QRS duration) with asymptomatic ventricular tachycardia was used. Such a combination was also the strongest index for sudden death in the first year after infarction in another prospective study [35] . Non-sustained ventricular tachycardia was pivotal in the risk stratification programmes that were most successful in identifying risk groups [9, 36] . This implies that it remains worthwhile to study spontaneous arrhythmias, even when pharmacological interventions focused on spontaneous arrhythmias were not successful. This type of non-sustained ventricular tachycardia is not helpful in predicting the outcome of programmed electrical stimulation, and the high risk is independent of the cycle length of the arrhythmia [36] , and the high risk is independent of the length of the arrhythmia. It was not helpful in our study to predict the outcome.
Most recent studies, confirming data from the prethrombolytic era [37] , used invasive procedures (programmed electrical stimulation) to define high risk groups [9, 10, 19] . Programmed ventricular stimulation was predictive for arrhythmic events, but yields a high number of false positives (82%) [19] . This is in contrast with our positive predictive value of 30%.
We feel that programmed stimulation could be a logical next step, and consider the omission of this procedure as the most important limitation of our study. However, it is not logical to exclude 'old' patients and those with a 'good' function, as sudden death strikes also in these groups. A good non-invasive risk assessment should be the first step in our attempts to prevent sudden death.
